SG Americas Securities’s Praxis Precision Medicines PRAX Stock Holding History

SG Americas Securities’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Buy	4,321 +3,469	+407%	+$1.1M	﹤0.01%	1661
2026 Q1	$275K	Sell	852 -9,113	-91%	-$2.82M	﹤0.01%	2502
2025 Q4	$2.94M	Sell	9,965 -3,531	-26%	-$658K	﹤0.01%	1333
2025 Q3	$715K	Buy	+13,496	New	+$654K	﹤0.01%	1783
2025 Q2	–	Sell	-3,004	Closed	-$114K	–	3449
2025 Q1	$114K	Buy	+3,004	New	+$188K	﹤0.01%	2948
2024 Q4	–	Sell	-5,158	Closed	-$297K	–	3513
2024 Q3	$297K	Buy	+5,158	New	+$279K	﹤0.01%	2155
2024 Q2	–	Sell	-2,465	Closed	-$150K	–	3217
2024 Q1	$150K	Buy	+2,465	New	+$111K	﹤0.01%	2208
2023 Q2	–	Sell	-1,147	Closed	-$14K	–	2982
2023 Q1	$14K	Buy	1,147 +231	+25%	+$9.75K	﹤0.01%	3178
2022 Q4	$33K	Sell	916 -272	-23%	-$8.48K	﹤0.01%	2889
2022 Q3	$40K	Sell	1,188 -2,094	-64%	-$104K	﹤0.01%	3027
2022 Q2	$121K	Buy	+3,282	New	+$350K	﹤0.01%	2997
2022 Q1	–	Sell	-642	Closed	-$190K	–	3335
2021 Q4	$190K	Sell	642 -657	-51%	-$193K	﹤0.01%	2691
2021 Q3	$360K	Buy	+1,299	New	+$352K	﹤0.01%	2784

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SG Americas Securities's PRAX Position: Q2 2026 in Review

SG Americas Securities increased its Praxis Precision Medicines (PRAX) stake by 407% in Q2 2026, buying an estimated $1.1M and bringing the position to 4,321 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

SG Americas Securities first reported a position in PRAX in Q3 2021 and has held it in 13 quarters since. The position peaked at $2.94M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

SG Americas Securities held 4,321 shares of Praxis Precision Medicines worth $1.45M as of Q2 2026.
SG Americas Securities bought 3,469 Praxis Precision Medicines shares in Q2 2026, an estimated $1.1M.
Praxis Precision Medicines made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1661 holding.
SG Americas Securities first reported a position in Praxis Precision Medicines in Q3 2021 and has held it in 13 quarters since.
SG Americas Securities's Praxis Precision Medicines position peaked at $2.94M in Q4 2025.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.